Skip Nav Destination
Issues
15 June 2017
-
Cover Image
Cover Image
Human prostate cancer selectively metastasizes to the bone with mechanisms that are partially unknown. RAGE is a receptor overexpressed by prostate cancer cells whose expression correlates with the capacity of colonizing the bone marrow microenvironment. Proteinase 3 (PR3) is a serine protease produced and released by myeloid cells, and has been identified as a RAGE-interacting protein. Using high resolution confocal microscopy, it was found that soluble PR3 (red) accumulates at the surface of prostate cancer cells overexpressing RAGE (green). This result supports further evidence of heterotypic cell-cell interactions between prostate cancer cells expressing RAGE and hematopoietic cells expressing PR3. For more details, see article by Kolonin and colleagues on page 3144.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Perspective
Priority Reports
Author Choice
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone
Mikhail G. Kolonin; Anna Sergeeva; Daniela I. Staquicini; Tracey L. Smith; Christy A. Tarleton; Jeffrey J. Molldrem; Richard L. Sidman; Serena Marchiò; Renata Pasqualini; Wadih Arap
Molecular and Cellular Pathobiology
Author Choice
Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis
Carolyn J. Loveridge; Ernest J. Mui; Rachana Patel; Ee Hong Tan; Imran Ahmad; Michelle Welsh; Julie Galbraith; Ann Hedley; Colin Nixon; Karen Blyth; Owen Sansom; Hing Y. Leung
TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis
Reem Malek; Rajendra P. Gajula; Russell D. Williams; Belinda Nghiem; Brian W. Simons; Katriana Nugent; Hailun Wang; Kekoa Taparra; Ghali Lemtiri-Chlieh; Arum R. Yoon; Lawrence True; Steven S. An; Theodore L. DeWeese; Ashley E. Ross; Edward M. Schaeffer; Kenneth J. Pienta; Paula J. Hurley; Colm Morrissey; Phuoc T. Tran
tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer
Bingqing Huang; Huipeng Yang; Xixi Cheng; Dan Wang; Shuyu Fu; Wencui Shen; Qi Zhang; Lijuan Zhang; Zhenyi Xue; Yan Li; Yurong Da; Qing Yang; Zesong Li; Li Liu; Liang Qiao; Ying Kong; Zhi Yao; Peng Zhao; Min Li; Rongxin Zhang
Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion
Hsin-Yu Chen; Peder E.Z. Larson; Robert A. Bok; Cornelius von Morze; Renuka Sriram; Romelyn Delos Santos; Justin Delos Santos; Jeremy W. Gordon; Naeim Bahrami; Marcus Ferrone; John Kurhanewicz; Daniel B. Vigneron
Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation
Katherine Tech; Andrey P. Tikunov; Hamza Farooq; A. Sorana Morrissy; Jessica Meidinger; Taylor Fish; Sarah C. Green; Hedi Liu; Yisu Li; Andrew J. Mungall; Richard A. Moore; Yussanne Ma; Steven J.M. Jones; Marco A. Marra; Matthew G. Vander Heiden; Michael D. Taylor; Jeffrey M. Macdonald; Timothy R. Gershon
Tumor and Stem Cell Biology
p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis
Hilaire C. Lam; Christian V. Baglini; Alicia Llorente Lope; Andrey A. Parkhitko; Heng-Jia Liu; Nicola Alesi; Izabela A. Malinowska; Darius Ebrahimi-Fakhari; Afshin Saffari; Jane J. Yu; Ana Pereira; Damir Khabibullin; Barbara Ogorek; Julie Nijmeh; Taylor Kavanagh; Adam Handen; Stephen Y. Chan; John M. Asara; William M. Oldham; Maria T. Diaz-Meco; Jorge Moscat; Mustafa Sahin; Carmen Priolo; Elizabeth P. Henske
IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition
Miriam Gaggianesi; Alice Turdo; Aurora Chinnici; Elisa Lipari; Tiziana Apuzzo; Antonina Benfante; Isabella Sperduti; Simone Di Franco; Serena Meraviglia; Elena Lo Presti; Francesco Dieli; Valentina Caputo; Gabriella Militello; Salvatore Vieni; Giorgio Stassi; Matilde Todaro
Therapeutics, Targets, and Chemical Biology
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Ariella B. Hanker; Mónica Valeria Estrada; Giampaolo Bianchini; Preston D. Moore; Junfei Zhao; Feixiong Cheng; James P. Koch; Luca Gianni; Darren R. Tyson; Violeta Sánchez; Brent N. Rexer; Melinda E. Sanders; Zhongming Zhao; Thomas P. Stricker; Carlos L. Arteaga
Microenvironment and Immunology
Integrated Systems and Technologies
An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
Ariosto Silva; Maria C. Silva; Praneeth Sudalagunta; Allison Distler; Timothy Jacobson; Aunshka Collins; Tuan Nguyen; Jinming Song; Dung-Tsa Chen; Lu Chen; Christopher Cubitt; Rachid Baz; Lia Perez; Dmitri Rebatchouk; William Dalton; James Greene; Robert Gatenby; Robert Gillies; Eduardo Sontag; Mark B. Meads; Kenneth H. Shain
Letter to the Editor
Correction
Advertisement